Profile | GDS4284 / 219799_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 515.006 | 64 |
GSM687648 | Patient 402 control | 548.674 | 65 |
GSM687653 | Patient 403 control | 240.655 | 53 |
GSM687658 | Patient 404 control | 1617.4 | 81 |
GSM687663 | Patient 411 control | 426.007 | 61 |
GSM687668 | Patient 422 control | 922.137 | 73 |
GSM687673 | Patient 424 control | 536.428 | 64 |
GSM687678 | Patient 425 control | 513.588 | 63 |
GSM687683 | Patient 427 control | 543.278 | 64 |
GSM687688 | Patient 428 control | 156.619 | 44 |
GSM687695 | Patient 441 control | 2131.22 | 86 |
GSM687699 | Patient 443 control | 1167.51 | 76 |
GSM687704 | Patient 444 control | 236.293 | 52 |
GSM687707 | Patient 448 control | 343.696 | 56 |
GSM687712 | Patient 449 control | 695.499 | 69 |
GSM687719 | Patient 450 control | 923.262 | 72 |
GSM687724 | Patient 451 control | 326.441 | 56 |
GSM687728 | Patient 452 control | 1118.16 | 76 |
GSM687646 | Patient 401 treated 24h | 551.727 | 64 |
GSM687649 | Patient 402 treated 24h | 395.881 | 60 |
GSM687665 | Patient 411 treated 24h | 578.583 | 65 |
GSM687651 | Patient 402 treated 4 weeks | 618.495 | 66 |
GSM687667 | Patient 411 treated 4 weeks | 496.932 | 63 |
GSM687670 | Patient 422 treated 24h | 886.633 | 72 |
GSM687671 | Patient 422 treated 4 weeks | 645.376 | 67 |
GSM687654 | Patient 403 treated 24h | 315.702 | 57 |
GSM687675 | Patient 424 treated 24h | 475.466 | 62 |
GSM687685 | Patient 427 treated 24h | 537.222 | 64 |
GSM687656 | Patient 403 treated 4 weeks | 242.098 | 54 |
GSM687677 | Patient 424 treated 4 weeks | 536.683 | 64 |
GSM687687 | Patient 427 treated 4 weeks | 322.856 | 57 |
GSM687692 | Patient 428 treated 4h | 363.038 | 59 |
GSM687716 | Patient 449 treated 4h | 394.045 | 60 |
GSM687722 | Patient 450 treated 4h | 670.901 | 67 |
GSM687680 | Patient 425 treated 24h | 590.043 | 66 |
GSM687690 | Patient 428 treated 24h | 323.591 | 58 |
GSM687700 | Patient 443 treated 24h | 1587.6 | 81 |
GSM687705 | Patient 444 treated 24h | 421.343 | 62 |
GSM687714 | Patient 449 treated 24h | 575.356 | 66 |
GSM687721 | Patient 450 treated 24h | 964.438 | 74 |
GSM687682 | Patient 425 treated 4 weeks | 388.896 | 60 |
GSM687694 | Patient 428 treated 4 weeks | 256.843 | 54 |
GSM687702 | Patient 443 treated 4 weeks | 982.586 | 73 |
GSM687718 | Patient 449 treated 4 weeks | 831.349 | 72 |
GSM687723 | Patient 450 treated 4 weeks | 549.103 | 65 |
GSM687661 | Patient 404 treated 4h | 1349.17 | 78 |
GSM687710 | Patient 448 treated 4h | 439.669 | 62 |
GSM687726 | Patient 451 treated 4h | 412.267 | 60 |
GSM687730 | Patient 452 treated 4h | 1565.44 | 82 |
GSM687660 | Patient 404 treated 24h | 8080.64 | 96 |
GSM687697 | Patient 441 treated 24h | 2642.63 | 88 |
GSM687709 | Patient 448 treated 24h | 435.917 | 61 |
GSM687725 | Patient 451 treated 24h | 558.823 | 65 |
GSM687729 | Patient 452 treated 24h | 2138.96 | 86 |
GSM687727 | Patient 451 treated 4 weeks | 441.767 | 61 |
GSM687731 | Patient 452 treated 4 weeks | 1532.73 | 80 |